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NEWS & NOTES
Meeting Summary
Bioterrorism-
Related Public 
Health Bacillus 
anthracis Research 
Priorities
During the 2001 anthrax bioterror-
ism investigation, several areas were
identified in which additional research
may improve public health response.
The disciplines and specific expertise
required to approach many of these
areas are varied and reside in multiple
entities in the federal government and
elsewhere. To identify, prioritize, and
coordinate short-term Bacillus anthra-
cis bioterrorism research for public
health response, the Centers for Dis-
ease Control and Prevention (CDC)
convened a meeting in Atlanta on
December 10–11, 2001, to obtain
input on research priorities and
improve coordination with federal
partners and other stakeholders. One
hundred thirty-two representatives
from the Department of Health and
Human Services (CDC, Food and
Drug Administration, and National
Institutes of Health), Environmental
Protection Agency, Department of
Defense, Department of Energy,
Department of Justice, U.S. Postal
Service, state health departments, uni-
versities, and other organizations par-
ticipated in the meeting. 
The meeting format consisted of
two plenary sessions. In the first ple-
nary session experts provided summa-
ries of key topic areas. Background
talks were given on evaluation of B.
anthracis–containing powders or sub-
stances; epidemiologic investigation;
environmental assessment; surveil-
lance; diagnosis; treatment; postexpo-
sure prophylaxis; and remediation. 
After the first plenary session, par-
ticipants were divided into eight pre-
assigned working groups, covering the
following topics: 1) evaluation of B.
anthracis–containing powders or sub-
stances; 2) epidemiologic investiga-
tion; 3) environmental assessment; 4)
surveillance; 5) diagnosis; 6) treat-
ment; 7) postexposure prophylaxis;
and 8) remediation. During the second
plenary session, each group presented
interim results to the larger group of
participants. In two working group
sessions, the topic-specific groups
identified their three top research pri-
orities and prepared a brief written
report describing proposed activities.
For evaluation of B. anthracis–
containing powders or substances, the
top three priorities were  1) rapid anal-
ysis of anthrax-containing powder:
particle size distribution and matrix
characteristics; 2) measurement of par-
ticle reaerosolization of different
anthrax powder preparations, and 3)
development of an in vitro model for
the study of cutaneous anthrax by
human cell culture. For epidemiologic
investigation, priorities were 1) analy-
sis of individual host risk factors for
anthrax infection; 2) exposure recon-
struction and risk characterization; and
3) review of unexamined or previously
unpublished (potentially classified)
animal data related to dose response.
For environmental assessment, the top
priorities were 1) validation and stan-
dardization of sampling and sample
analysis techniques; 2) evaluation of
risk of disease in contaminated envi-
ronments; and 3) determination of risk
of reaerosolization. For surveillance,
priorities were 1) expanded veterinary
surveillance and integration with
human health information; 2)  use of
alternative sources of data in the sur-
veillance for bioterrorism-related
events; and 3) design and validation of
surveillance systems to detect complex
contamination or release scenarios.
For diagnosis, priorities were 1) identi-
fication of the earliest detectable event
in the continuum from exposure to
anthrax to disease (using animal mod-
els); 2) evaluation of antigen-detection
assays; and 3) development of a
library of B. anthracis subtypes. For
treatment, priorities were 1) investiga-
tion of the role of immune and anti-
toxin therapies; 2) expanded
investigation of antibiotic therapies in
animal models; and 3) development of
other animal models. For postexposure
prophylaxis, priorities were 1) evalua-
tion of adherence, barriers to adher-
ence, and adverse events associated
with long-term use of antimicrobial
agents; 2) pediatric anthrax vaccine
safety and immunogenicity studies;
and 3) animal challenge studies to
optimize postexposure prophylaxis in
humans. For remediation, the top three
priorities were 1) evaluation of reme-
diation agents; 2) development of risk-
based decision templates for sampling
and remediation; and 3) reaerosoliza-
tion studies and agent- and space-spe-
cific scenarios.
This meeting defined a framework
and set specific priorities for additional
research needed to improve public
health response to B. anthracis–related
bioterrorism. Explanations of why the
research was considered important,
what the research would be, how it
would be carried out, who could do it,
and when it could begin are available
online from URL: http://www.cdc.gov/
ncidod/dbmd/diseaseinfo/files/MeetingRe-
port _BTPriorities_Dec1011.pdf 
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